HDAC Inhibitor-Mediated Radiosensitization in Human Carcinoma Cells: A General Phenomenon?
スポンサーリンク
概要
- 論文の詳細を見る
Histone deacetylase inhibitors (HDIs) have attracted considerable attention for anticancer therapy strategy, including radiosensitization. Regarding a potential application of HDI as a radiosensitizer in the treatment of solid tumors, an important question is whether treatment efficacy would be influenced by intrinsic differences between cancer cells, such as different histologic origin and status of ATM or p53. First we have observed the in vitro radiosensitization by Trichostatin A (TSA) on the broad spectrum of human tumor cell lines having different histologic origin such as HCT116 adenocarcinoma of colon, A549 adenocarcinoma of lung, HN-3 squamous cell carcinoma of head/neck, and HeLa squamous cacinoma of uterine cervix, using clonogenic assay. Next, we have systematically assessed the radiosensitization on the cell lines having different ATM or p53 status. We found that pretreatment of HDI consistently resulted in radiosensitization of all cell lines tested, though the sensitizer enhancement ratio of individual cell lines was variable. We also observed that TSA-mediated radiosensitization was clearly influenced by p53 and ATM status of cells tested. The data presented here indicate that HDI enhances the radiation induced cell killing in the various cancer cells having intrinsic differences and may serve as a general strategy for enhancing tumor cell radiosensitivity. These results have potential implications for the clinical utility of HDI in increasing the anticancer efficacy of radiation.
論文 | ランダム
- 潰瘍性大腸炎モデルにおける1, 2-dimethylhydrazine (DMH)誘発大腸癌とPSKの抑制効果
- 大血管合併切除により完全切除し得た後腹膜悪性腫瘍の検討
- 肝細胞癌におけるMKP-1発現の生物学的意義に関する研究(第105回日本外科学会定期学術集会)
- 大腸, 直腸癌における galectin-3発現と臨床的意義に関する研究(第105回日本外科学会定期学術集会)
- アンケート調査からみた直腸癌に対する側方郭清の現状と今後の課題(第105回日本外科学会定期学術集会)